Topic: SPUTNIK V
ZyCoV-D: World’s first DNA-based Vaccine
Indian pharmaceutical company Zydus Cadila is soon going to apply Central Drugs Regulator (DGCI) for emergency approval of the corona vaccine ZyCoV-D. If approved, it will be the...
2DG- DRDO’s Anti-Covid Drug
On May 17, 2021, the DRDO released the first batch of 2-DG drugs. The 2-DG was developed by the Defence Research Development Organisation for Emergency Use. 2-DG is...
Sputnik V: First Dose administered at Rs 995
On May 14, 2021, Dr Reddy’s Laboratories announced that it had launched Sputnik V in India. The vaccine is imported from Russia. And is distributed by Dr Reddy’s...
What is Sputnik Light Single Dose?
Sputnik V vaccine developed by Russia is a two-dose vaccine. The unique feature of the vaccine is that the first and second dose are different from each other....
India-Russia 2+2 Dialogue
The Prime Minister Narendra Modi and the Russian President Vladimir Putin recently agreed to establish “2+2 Ministerial Dialogue”. The “2+2 Ministerial” dialogue is held between the defence ministers...
Brazil: Sputnik V vaccine supply had live cold virus
The Health Regulator of Brazil recently announced that the Sputnik V vaccines of Russia carried live cold virus. It has thus raised questions about the integrity of the...
Why is GoI fast tracking the Emergency use of foreign made COVID-19 Vaccines?
The Government of India recently announced that it is speeding up the Emergency Usage Approvals of foreign made COVID-19 vaccines. This includes COVID-19 vaccines that have been granted...
India: Expert panel recommends approval to Sputnik V vaccine
An Expert panel of the Central Drugs Standard Control Organisation (CDSCO) recently approved the Emergency Use of COVID-19 vaccine Sputnik-V. However, the Drugs Controller General of India (DGCI)...
What is Carnivac-Cov Vaccine?
The first animal vaccine against the novel coronavirus in the world has been registered in Russia. It was announced by the country’s agriculture safety watchdog Rosselkhoznadzor. Key Points...
India approved two COVID-19 vaccines for Emergency Use
The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved...
COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India
On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to... 